Live from the NIH registry
Studies recruiting near Round Lake Beach right now
Top 25 of 470 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
AMG Libertyville - Oncology — Libertyville, Illinois (9.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10041, Island Lake, IL — Island Lake, Illinois (9.1 mi)
· Sponsor: Colorado Prevention Center
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Orchard Healthcare Research Inc. — Skokie, Illinois (29.8 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
City of Hope® Cancer Center Chicago — Zion, Illinois (13.5 mi)
· Sponsor: Hoffmann-La Roche
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Niles, Illinois (28.7 mi)
· Sponsor: Daiichi Sankyo
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Endeavor Health Clinical Trials Center — Skokie, Illinois (29.8 mi)
· Sponsor: Celldex Therapeutics
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northwestern Medicine Grayslake Outpatient Center — Grayslake, Illinois (3.1 mi)
· Sponsor: SWOG Cancer Research Network
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
Endeavor Health Skokie Hospital — Skokie, Illinois (29.8 mi)
· Sponsor: Elute, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
AMG Libertyville - Oncology — Libertyville, Illinois (9.3 mi)
· Sponsor: NRG Oncology
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Niles, Illinois (28.7 mi)
· Sponsor: AstraZeneca
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (20.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
Healthy Volunteers
Phase 1
Interventional 66 participants sought
Acpru /Id# 279789 — Grayslake, Illinois (3.1 mi)
· Sponsor: AbbVie
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Endevour Health — Skokie, Illinois (29.8 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
Common Warts, Common Warts (Verruca Vulgaris)
Phase 3
Interventional 300 participants sought
Endeavor Health — Skokie, Illinois (29.8 mi)
· Sponsor: Verrica Pharmaceuticals Inc.
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.2 mi)
· Sponsor: Washington University School of Medicine
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Endeavor Health — Skokie, Illinois (29.8 mi)
· Sponsor: Novo Nordisk A/S
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Northwestern Medicine Grayslake Outpatient Center — Grayslake, Illinois (3.1 mi)
· Sponsor: NRG Oncology
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Allergic Reactions
Phase 4
Interventional 600 participants sought
Endeavor Health — Glenview, Illinois (26.1 mi)
· Sponsor: ARS Pharmaceuticals, Inc.
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Glaucoma, Open-angle, Ocular Hypertension (OHT)
Phase 4
Interventional 132 participants sought
Glaukos Investigator Site — Kenosha, Wisconsin (19.4 mi)
· Sponsor: Glaukos Corporation
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Open Angle Glaucoma (OAG)
N/A
Interventional 165 participants sought
The Eye Centers of Racine & Kenosha — Kenosha, Wisconsin (19.4 mi)
· Sponsor: Avisi Technologies Inc.
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Ascension All Saints Hospital-Spring Street-Racine — Racine, Wisconsin (28.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Glenview, IL Investigative Site 10021 — Glenview, Illinois (26.1 mi)
· Sponsor: Colorado Prevention Center
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1148 — Elgin, Illinois (25.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Investigations of Reproductive Cancers in Women
Uterine Cancer
N/A
Observational 4,500 participants sought
Ob-Gyne Associates of Lake Forest, Ltd — Lake Forest, Illinois (14.8 mi)
· Sponsor: PinkDx, Inc.
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Perinatal Decision Making
N/A
Interventional 2,200 participants sought
Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital — Lake Forest, Illinois (14.8 mi)
· Sponsor: Endeavor Health